• WebBanner_688x217_CoverPhoto_r1-01

  • slide_prepvideos

  • slide_adaywithhiv

  • Slideshow_knowmorehepc

  • Slideshow_hivhealthreform

IAS2013: Potential HIV remission in two transplant recipients

post_ias2013

7th International AIDS Society Conference, Kuala Lumpur, June 2013: Researchers have reported that two HIV-positive men who received stem cell transplants to treat their cancer have no detectable HIV despite interrupting HIV treatment for at least seven weeks. These data, presented Wednesday, July 3 at the…Read More

Project Inform applauds changes to final recommendations on hepatitis C testing

pic_uspstf_gradeb

Project Inform applauds the U.S. Preventive Services Task Force (USPSTF) for making a significant change in the release of its updated hepatitis C screening recommendations to test all people born between 1945 and 1965, as well as those who are at risk of infection. In August…Read More

New patient assistance program available for HIV-related diarrhea medication Fulyzaq

PAPs

The manufacturer of Fulyzaq (crofelemer), Salix Pharmaceuticals, announced that it now has a patient assistance program (PAP) established for their medication. The drug was approved by the FDA earlier in late December 2012 to treat HIV-associated diarrhea. For those individuals without insurance and who qualify for the…Read More

WEBINAR: Integrating Community-Based Organizations and New Health Care Reform Health Homes

post_hivhealthreform

Reserve your spot today for the June 20 webinar.   Pathways to Collaboration: Integrating Community-Based Organizations and New Health Care Reform Health Home Programs Thursday, June 20, 11am–12pm PT, 12-1pm MT, 1-2pm CT, 2-3pm ET Register today. The Affordable Care Act (ACA) is daunting for community-based HIV organizations that…Read More

FDA grants priority review for sofosbuvir, new drug for curing hepatitis C

post_priority

On Friday, June 7, the maker of the experimental drug sofosbuvir announced that the drug had been given priority review status by the FDA. The FDA grants this status to drug candidates that may offer major advances in treatment over existing options. In clinical studies, some…Read More

New service matches HIV+ individuals to HIV research studies

nurse

A non-profit service provided through Vanderbilt University in Nashville has launched a new initiative to help link people with HIV who are interested in participating in research with researchers who are conducting new studies on HIV medications. The service, ResearchMatch, let’s interested parties enter as much…Read More

HIV care linkage and re-engagement webinar recording now live

webinar

On May 29th, Project Inform held a webinar to share the results of a Think Tank held in November 2012 to develop policies and procedures to guide the use of HIV laboratory data for the purpose of engaging or re-engaging HIV-positive people in health care. The…Read More